novo nordisk semaglutide nash Nordisk's diabetes med shows promise in NASH. Can it deliver in phase 3? Novo Nordisk's weight-loss pill wins
Description
I love PB
However, overtime researchers discovered that these medications also show remarkable promise for weight management
The examples below illustrate a 15% body-weight change
The corresponding changes in body weight and systolic blood pressure were 7.6% (95% CI 8.6, 6.6) and 4.8 mmHg (95% CI 6.7, 2.9), respectively, for semaglutide 2.4 mg versus placebo (14)
SEM Used in Mixed Population (as Second- or Third-Line Therapy, Add-On to Standard of Care) Efficacy of study medications on body weight in SUSTAIN-6 was presented in Table 33
This prevents your body from breaking down muscle tissue as it burns fat
00068-7/asset/fd53a887-7fc5-47e3-8cb1-2f290875bdb9/main.assets/gr3_lrg.jpg)
